JW Lifescience Corporation (234080.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩10,440 (+0.19%) as of
Key statistics
- Market cap
- 161.66B
- Dividend yield
- 5.28%
- 52-week range
- 10,330.00 – 15,580.00
- Beta
- 0.22
- Revenue (TTM)
- 253.71B
- Profit margin
- 10.26%
- Volume
- 9.67k
About JW Lifescience Corporation
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Dangjin-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.